Sarepta Therapeutics SRPT
NASDAQ SRPT
$17.50 -0.07 (-0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Gross Profit (2017 - 2026)

Updated

Sarepta Therapeutics (SRPT) posted Gross Profit of $251.87 million for Q2 2026, down 45.1% from $458.53 million a year earlier and down 59.5% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Gross Profit (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Profit at Sarepta Therapeutics was $1.17 billion, down 40.7% year-over-year; for FY2025, it came in at $1.36 billion, down 14.2% from FY2024.

  • Annual Gross Profit shows a five-year compound annual growth rate of 23.3% (FY2020 to FY2025).
  • In prior years, Sarepta Therapeutics' Gross Profit was $1.58 billion in FY2024 (+44.8%), $1.09 billion in FY2023 (+37.8%), $793.02 million in FY2022 (+31.1%) and $604.84 million in FY2021 (+26.9%).
  • Quarterly Gross Profit has run from a low of $44.23 million in Q4 2025 to a high of $622.04 million in Q1 2026 over five years.
  • On a year-over-year basis, Gross Profit increased in five of the last eight quarters, with growth averaging 2.5%.
  • The strongest year-over-year quarter for Gross Profit in the past five years was Q1 2025, with growth of 67.3%; the weakest was Q4 2025, with a decline of 91.6%.
  • According to Business Quant data, Gross Profit for the three prior quarters was $622.04 million (Q1 2026), $44.23 million (Q4 2025) and $248.58 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Sarepta Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=SRPT&period=max&api_key=YOUR_API_KEY